Literature DB >> 1188306

The incidence of Crohn's disease in central Sweden.

L Bergman, U Krause.   

Abstract

In an earlier epidemiological study covering a 12-year period from 1956-67, a gradual increase in the number of patients with Crohn's disease was found. A study of the subsequent 6 years, from 1968-73, is now presented. The mean incidence of the disease for this period is 5.0, compared with 3.1 for the preceding 6 years, 1962-67. As in the earlier 12-year series, the increasing incidence can be attributed largely to an increase in the 15-29 year age group. During the period 1956-67, the disease occurred almost as frequently in men as in women. In the 6-year period now presented, there is a predominance of women, especially over the age of 35.

Entities:  

Mesh:

Year:  1975        PMID: 1188306

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982.

Authors:  J H Gollop; S F Phillips; L J Melton; A R Zinsmeister
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

2.  Trends in incidence rates of ulcerative colitis and Crohn's disease.

Authors:  B M Calkins; A M Lilienfeld; C F Garland; A I Mendeloff
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

3.  Fall in the incidence of Crohn's disease.

Authors:  J Kyle; G Stark
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

4.  Incidence of Crohn's disease in Stockholm County 1955-1989.

Authors:  A Lapidus; O Bernell; G Hellers; P G Persson; R Löfberg
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

5.  Incidence of inflammatory bowel disease in northern France (1988-1990).

Authors:  C Gower-Rousseau; J L Salomez; J L Dupas; R Marti; M C Nuttens; A Votte; M Lemahieu; B Lemaire; J F Colombel; A Cortot
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

6.  Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease.

Authors:  Rebecca Munk Vejborg; Viktoria Hancock; Andreas M Petersen; Karen A Krogfelt; Per Klemm
Journal:  BMC Genomics       Date:  2011-06-15       Impact factor: 3.969

7.  Cost-effectiveness of ustekinumab in moderate to severe Crohn's disease in Sweden.

Authors:  Amanda Hansson-Hedblom; Chrissy Almond; Fredrik Borgström; Indeg Sly; Dana Enkusson; Anders Troelsgaard Buchholt; Linda Karlsson
Journal:  Cost Eff Resour Alloc       Date:  2018-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.